This inventor holds 2 USPTO granted patents. Top assignee: Miles Laboratories, Inc.. Active years: 1976-1980.
Company Filing History:
Years Active: 1976-1980
Title: Horacio Vidrio: Innovator in Cardiovascular Treatments
Introduction
Horacio Vidrio is a notable inventor based in Mexico City, MX. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds for treating cardiovascular disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Vidrio's latest patents include innovative compounds such as 2-Aminooctahydroindolo[2,3-a]quinolizines. These compounds are designed to treat various cardiovascular issues, including cardiac arrhythmia, hypertension, and angina pectoris. The structural formula of these compounds allows for various substitutions, making them versatile in their application. Additionally, he has developed derivatives of 2-Substituted-hydroxyanilino-hexahydro-2H-benzo[.alpha.]quinolizines, which exhibit coronary vasodilating activity.
Career Highlights
Horacio Vidrio is associated with Miles Laboratories, Inc., where he has been instrumental in advancing research in cardiovascular treatments. His innovative approach and dedication to improving health outcomes have earned him recognition in the scientific community.
Collaborations
Throughout his career, Vidrio has collaborated with esteemed colleagues such as Herbert J Havera and Richard Dana Johnson. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.
Conclusion
Horacio Vidrio's contributions to the field of cardiovascular treatments through his patents and collaborations highlight his role as a significant innovator. His work continues to pave the way for advancements in medical science.